Ballad Health, a 20-hospital system with the nation's largest state-sanctioned hospital monopoly, serves patients in ...
California lawmakers are moving to rein in the pharmaceutical middlemen they say drive up costs and limit consumers’ choices.
The Democratic measure, which would have ensured federal protections to the fertility treatment, failed 51-44. The GOP bill, which focused on access to IVF, did not gain unanimous consent to pass.
Even though cancer death rates have fallen, the report notes, moderate and light drinkers saw more cancer deaths than occasional drinkers.
The policy initiative previously was proposed by President Joe Biden. Meanwhile, the U.S. House today is set to vote on funding the government. The Washington Post reports that it doesn't have enough ...
When the Agriculture Department posted a recall of chicken nuggets that might be contaminated, it directed consumers to return them or throw the stuff away. When the Consumer Product Safety Commission ...
The New York Times: Deep Links Between Alcohol And Cancer Are Described In New Report Adults under age 50 have been developing breast cancer and colorectal cancer at increasingly higher rates ...
The Hill: America Can't Afford The High Cost Of Prescription Drugs For many Americans, their confidence in the future of U.S. healthcare is low and their insecurity due to the cost of medicine ...
The botanical has been used for centuries in Southeast Asia, Bloomberg notes, but it's more commonly found in drinks and concentrates in the U.S., triggering the research effort. Separately, financial ...
The respiratory virus is linked, in rare cases, to acute flaccid myelitis, which affects the nervous system. Meanwhile, flu deaths among kids for the 2023-24 season tied the U.S. record high of 199.
The goal is to reduce the impact of incorrect diagnoses, or delayed ones, which can occur for many different reasons and seriously impact the safety of patient care. Among other news, New Hampshire’s ...
Also, Sen. Bernie Sanders spoke up again about Ozempic's manufacturer Novo Nordisk, alleging that it can make and sell its weight loss drug for under $100 a month. Meanwhile, CNN notes that GLP-1 ...